Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases—a single-center experience

CC Pieper, C Meyer, KE Wilhelm, W Block… - Journal of Vascular and …, 2016 - Elsevier
Purpose To determine value of transarterial radioembolization (TARE) for palliative
treatment of unresectable liver-dominant breast metastases (LdBM) and to determine …
被引用次数：46 相关文章 所有 4 个版本
[HTML] nih.gov

Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy

AC Gordon, WJ Gradishar, VG Kaklamani… - Journal of Vascular and …, 2014 - Elsevier
Purpose To determine, in an open-label, retrospective report, the safety and effectiveness of
locoregional therapy with yttrium-90 (90 Y) radioembolization for patients with progressing …
被引用次数：71 相关文章 所有 8 个版本

Predictors of survival after yttrium-90 radioembolization of chemotherapy-refractory hepatic metastases from breast cancer

NA Davisson, ZL Bercu, SC Friend, E Paplomata… - Journal of Vascular and …, 2020 - Elsevier
Purpose To determine predictors of survival after transarterial radioembolization of hepatic
metastases from breast cancer. Materials and Methods Twenty-four patients with …
被引用次数：13 相关文章 所有 4 个版本
[PDF] researchgate.net

Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients

A Saxena, J Kapoor, B Meteling, DL Morris… - Annals of surgical …, 2014 - Springer
Introduction There are a paucity of data on the treatment of unresectable, chemoresistant
breast cancer liver metastases (BRCLM) with yttrium-90 (Y90) radioembolization. Methods …
被引用次数：68 相关文章 所有 6 个版本

Radioembolization in patients with hepatic metastases from breast cancer

TF Jakobs, RT Hoffmann, T Fischer… - Journal of Vascular and …, 2008 - Elsevier
PURPOSE: To determine the safety of and survival outcomes associated with single-
session, whole-liver radioembolization with Yttrium-90 (90Y)-labelled resin microspheres in …
被引用次数：132 相关文章 所有 6 个版本
[HTML] nih.gov

Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer

F Ridouani, MM Soliman, RW England, M Hsu… - European journal of …, 2021 - Elsevier
Purpose To determine the relationship of tumoral and nontumoral radiation dose to
response and toxicity after transarterial radioembolization (TARE) of breast cancer liver …
被引用次数：10 相关文章 所有 7 个版本
[HTML] sciencedirect.com

[HTML][HTML] Transarterial yttrium-90 glass microsphere radioembolization of chemotherapy-refractory breast cancer liver metastases: results of a single institution …

E Barakat, A Bibok, A Rishi, A Ahmed, JM Frakes… - Advances in Radiation …, 2022 - Elsevier
Purpose Our purpose was to retrospectively evaluate the safety and efficacy of transarterial
hepatic radioembolization (TARE) treatment with yttrium-90 labeled glass microspheres in …
被引用次数：6 相关文章 所有 7 个版本

90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival

AK Bangash, B Atassi, V Kaklamani, TK Rhee… - Journal of Vascular and …, 2007 - Elsevier
PURPOSE: To present data from patients with breast cancer liver metastases who
underwent radioembolization with yttrium (90Y) microspheres. MATERIALS AND …
被引用次数：116 相关文章 所有 7 个版本
[HTML] nih.gov

[HTML][HTML] Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: a systematic review

M Feretis, A Solodkyy - World Journal of Gastrointestinal Oncology, 2020 - ncbi.nlm.nih.gov
BACKGROUND Liver metastases secondary to breast cancer are associated with
unfavourable prognosis. Radioembolization with ytrrium-90 is an emerging option for …
被引用次数：16 相关文章 所有 5 个版本

Intra-arterial radioembolization of breast cancer liver metastases: a structured review

MLJ Smits, JF Prince, CENM Rosenbaum… - European journal of …, 2013 - Elsevier
Radioembolization using yttrium-90 microspheres (90Y-RE) is an emerging treatment option
for breast cancer liver metastases (BCLM) patients if other locoregional and systemic …
被引用次数：30 相关文章 所有 6 个版本